Scope
This ATS guideline addresses four selected questions in adult community-acquired pneumonia: diagnostic ultrasound, antibiotics after positive respiratory-virus testing, antibiotic duration after clinical stability, and systemic corticosteroids. Its recommendations distinguish outpatient comorbidity status and inpatient severity rather than providing a complete pneumonia-management pathway.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Diagnostic imaging
- For adults with suspected CAP, lung ultrasound is suggested as an acceptable alternative to chest radiography where the medical centre has appropriate clinical expertise. This recommendation is conditional, with low-quality evidence. [1]
Positive respiratory-virus testing
- For adult outpatients without comorbidities who have clinical and imaging evidence of CAP and a positive respiratory-virus test, the panel conditionally suggests withholding empiric antibiotics. Evidence is very low quality, and the benefit–harm balance depends on the clinical context. [1]
- For adult outpatients with comorbidities, clinical and imaging CAP, and a positive respiratory-virus test, empiric antibiotics are conditionally suggested because of bacterial–viral coinfection concerns. Evidence is very low quality; the clinical context can change the balance of benefits and harms. [1]
- For adult inpatients with nonsevere CAP supported by clinical and imaging findings and a positive respiratory-virus test, empiric antibiotics are conditionally suggested because bacterial–viral coinfection remains a concern. Evidence is very low quality and treatment depends on the clinical context. [1]
- For adult inpatients with severe CAP, clinical and imaging evidence and a positive respiratory-virus test, empiric antibiotics are also suggested for possible bacterial–viral coinfection. The recommendation remains conditional, with very low-quality evidence and no comparative evidence, despite committee unanimity. [1]
Duration after clinical stability
- For adult outpatients who reach clinical stability, the panel suggests less than 5 days of antibiotics, with a minimum of 3-d duration, rather than 5 or more days. This is a conditional, low-quality-evidence recommendation requiring individualization. [1]
- For clinically stable adult inpatients with nonsevere CAP, the panel similarly suggests less than 5 days, with a minimum of 3-d duration, rather than 5 or more days. This conditional recommendation requires individualization and is based on low-quality evidence. [1]
- For adult inpatients with severe CAP who become clinically stable, use 5 or more days rather than less than 5 days. This is a strong recommendation despite low-quality evidence, because insufficient therapy may cause serious adverse outcomes or death. [1]
Systemic corticosteroids
- Systemic corticosteroids should not be administered for adult inpatient nonsevere CAP. The recommendation against is strong despite low-quality evidence and seeks to avoid harmful effects, including hyperglycaemia. [1]
- For adult inpatients with severe CAP, systemic corticosteroids are conditionally suggested on low-quality evidence. This recommendation excludes severe CAP caused by influenza pneumonia. [1]
Limitations and use
- Only the ten recommendations across the four selected questions are summarized; this is not a complete CAP pathway or a drug-selection guide.
- The source refers to contextual factors in its separate table for antibiotic decisions and short-course therapy; that detailed table is not included here.
- These recommendations concern adults and should not be transferred to children.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Community-acquired pneumonia: selected diagnostic and treatment questions
Selected recommendation material consulted
Publication details
- Issuing organisation
- American Thoracic Society
- First published
- 18 July 2025
- Resource type
- Clinical guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.